Topics

Inovio Publishes Patient Benefit Results From Clinical Study In RRP

08:46 EST 3 Feb 2020 | FinanzNachrichten

WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 or HPV ...

Original Article: Inovio Publishes Patient Benefit Results From Clinical Study In RRP

NEXT ARTICLE

More From BioPortfolio on "Inovio Publishes Patient Benefit Results From Clinical Study In RRP"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...